Back

The IIISAS trial: a randomized controlled trial designed to assess the effect of ferric derisomaltose on physical capacity in patients with aortic stenosis and iron deficiency undergoing TAVI

29 June 2021 (08:00 - 23:59)
Organised by:
Congress Presentation Part of: ePoster session Intervention HFA Premium Access Heart Failure 2021

About the speaker

Photo
Miss Sara Bardan

University of Oslo, Oslo (Norway)

738 More presentations in this session

Presentation thumbnail
Atrial lead insertion during cardiac implantable electronic devices implantation in patients with atrial arrhythmia on hospital admission, when does the struggle for sinus rhythm make sense?
Assistant Professor N. Radovanovic (Belgrade, RS)
Abstract Slides
Presentation thumbnail
Features of the remodeling of atria and pulmonary veins in CHF patients with paroxysmal AF and permanent AF
Assistant Professor V. Kirillova (Ekaterinburg, RU)
Abstract Slides
Presentation thumbnail
Rhythm control versus rate control in patients with atrial fibrillation and heart failure across the left ventricular ejection fraction spectrum
Doctor D. Moysidis (Zurich, CH)
Abstract Slides
Presentation thumbnail
Impact of cardiac contractility modulation on ventricular rhythm and conduction disorders in patients with heart failure with reduced ejection fraction and various forms of atrial fibrillation
Doctor A. Safiullina (Moscow, RU)
Abstract Slides
Presentation thumbnail
Was a difference between late and early new-onset of atrial fibrillation in non st-elevation myocardial infarction?
Doctor H. Santos (Lisboa, PT)
Abstract Slides

Access the full session

Session thumbnail
ePoster session

The Event

Event poster

Heart Failure 2021

29 June 2021 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Does repletion of iron stores improve physical capacity after TAVI? - a substudy of the IIISAS randomised trial
20 May 2023
thumbnail
Congress Presentation
IRONMAN
22 May 2023
thumbnail
Congress Presentation
Testing for iron deficiency and use of ferric carboxymaltose in patients with heart failure: need for implementation? data from the swedish heart failure registry
29 June 2021
thumbnail
Congress Presentation
Maximal functional capacity response to physical therapies according to ferrokinetics in heart failure with preserved ejection fraction. A substudy of the training-hf trial
21 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources